We found significantly reduced expression of NKp30 (9.93% to 2.19%, p=0.010) but increased NKp44 expression (37.93% to 61.08%, p=0.018) in the NKp80+ ILC population in HCC patients after ICI treatment. This evidence concerns the gene NCR2 and hepatocellular carcinoma.